top of page

European Medicines Agency post-authorisation procedural advice for users of the centralised procedur

This guidance document addresses a number of questions which marketing authorisation holders (MAHs) may have on post-authorisation procedures. It provides an overview of the Agency’s position on issues, which are typically addressed in discussions or meetings with MAHs in the post-authorisation phase.


READ MORE



#LegislationRegulatoryAffairs #RegulatoryAffairsHuman

Today's News
Follow us
  • LinkedIn Social Icon
  • Vimeo Social Icon
Newsletter on Pharma Legislation
the newsletter of
bottom of page